MARATTO

article · Nutrition and Cancer

Possible Protective Potency of Argun Nut ( <i>Medemia argun</i> – An Ancient Egyptian Palm) against Hepatocellular Carcinoma in Rats

Abstract

<b>Introduction</b>Hepatocellular carcinoma (HCC) is one of the most common cancers worldwide. <i>Medemia argun</i> (MA) fruits have been found to possess proanthocyanidins (PACs), having antioxidant activity. <b>Methods:</b> Intraperitoneal (IP) diethyl nitrosamine (DENA; 200 mg/kg, once) and carbon tetra chloride (CCl<sub>4</sub>, 3 ml/kg/week, subcutaneously, for 6 weeks) induced HCC in rats. Animals groups: Group I; received vehicle (control). Group II; received MA seed extract, 100 mg/kg (twice/week) for 12 weeks, IP. Group III; received carcinogenic agents only. Group IV; received MA for two weeks before administration of DENA/CCl<sub>4</sub> till the end of the experiment. The total period of the experiment was three months. <b>Results:</b> DENA and CCl4 induced HCC, elevated serum alpha-fetoprotein (AFP), liver size, weight, tissue lymphocytic infiltration, nuclear/cytoplasmic ratio, collagen fiber and polysaccharide deposition, cellular proliferation, excessive pro-apoptotic caspase-3 accumulation, disrupted apoptosis. MA prior to DENA/CCl<sub>4</sub>, significantly protected liver against cancer progression, indicated by serum enzymes, antioxidant markers(glutathione, nitric oxide, and depressed malondialdehyde contents) in the MA-pretreated group, compared to the HCC one, without apparent useful action on superoxide dismutase activity, enhanced apoptosis in liver, through increased casapase-3 expression. The HCC group showed decreased antioxidant defense and BAX/<i>Bcl-2</i> ratio. <b>Conclusions:</b> This study assumes that MA has a chemo-preventive effect against hepatocarcinogenesis.

Research topics

  • Drug-Induced Hepatotoxicity and Protection
  • Liver Disease Diagnosis and Treatment
  • Curcumin's Biomedical Applications

Sustainable Development Goals

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.1080/01635581.2021.1883683

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.